Oral Presentation 3

[OP3-01] Primary resistance to nivolumab plus ipilimumab therapy in patients with metastatic renal cell carcinoma

*Kazuyuki Numakura¹, Yuya Sekine¹, Shingo Hatakeyama², Yumina Muto¹, Ryuta Sobu¹, Mizuki Kobayashi¹, Hajime Sasagawa¹, Soki Kashima¹, Ryohei Yamamoto¹, Taketoshi Nara^1,3, Hideo Akashi³, Ryuji Tabata⁴, Satoshi Sato⁴, Mitsuru Saito¹, Shintaro Narita¹, Chikara Ohyama², Tomonori Habuchi¹ (1. Akita University Graduate School of Medicine, 2. Hirosaki University Graduate School of Medicine, 3. Akita University Graduate School of Medicine, 4. Ageo Central General Hospital)